Drugmaker Merck has asked US regulators to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the world’s arsenal against the pandemic. Merck reported earlier this month that in clinical trials, the pill cut hospitalizations and deaths by half among patients with early symptoms of COVID-19. Since the pandemic started, health experts have stressed the need for a convenient pill that would be something like Tamiflu, the flu medication that shortens the illness and blunts the severity of symptoms.
Today we took the next step in helping in the fight against #COVID19 by applying for Emergency Use Authorization in the U.S. for our investigational antiviral treatment. We look forward to working with the FDA on its review of our application. pic.twitter.com/qBF8vqW4Vi
— Merck (@Merck) October 11, 2021
Photo Credit: Merck via Twitter